BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liang CM, Kuo MT, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK, Taiwan Acid-Related Disease Study Group. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World J Gastroenterol 2017; 23(47): 8395-8404 [PMID: 29307999 DOI: 10.3748/wjg.v23.i47.8395]
URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8395.htm
Number Citing Articles
1
I. V. Maev, J. V. Selskaya, D. N. Andreev, D. T. Dicheva, Z. N. Bogolepova, E. I. Kuznetsova. Laryngopharyngeal reflux: clinical significance, modern approaches to diagnosis and treatmentMedical Council 2019; (3): 8 doi: 10.21518/2079-701X-2019-3-8-16
2
Natalie Elliott, Amie Steel, Bradley Leech, Wenbo Peng. Design characteristics of comparative effectiveness trials for the relief of symptomatic dyspepsia: A systematic reviewIntegrative Medicine Research 2021; 10(2): 100663 doi: 10.1016/j.imr.2020.100663